Title of article :
Commentary: Planning and management to control and eliminate HTLV-1 infection in Iran
Author/Authors :
Boostani ، Reza Department of Neurology - Mashhad University of Medical Sciences , Lotfinejad ، Nasim Department of Research - Faculty of Medicine - Mashhad University of medical sciences , Zemorshidi ، Fariba Department of Neurology - Mashhad University of Medical Sciences , Vahidi ، Zohreh Inflammation and Inflammatory Diseases Division - Immunology Research Centre - Mashhad University of Medical Sciences , Rezaee ، Abdolrahim Inflammation and Inflammatory Diseases Division - Immunology Research Centre - Mashhad University of Medical Sciences , Farid ، Reza Allergy Research Centre - Mashhad University of Medical Sciences , Rafatpanah ، Houshang Inflammation and Inflammatory Diseases Division - Immunology Research Centre - Mashhad University of Medical Sciences
Abstract :
Prevention and treatment of the Human T-cell leukemia virus, type 1 (HTLV-1) which was discovered nearly 40 years ago, still remain challenging. The reported high prevalence of HTLV-1 in some countries around the world triggered an open letter to the World Health Organization (WHO), urging action against HTLV-1 infection in 2018. This highlights the importance of virus elimination strategies to eradicate HTLV-1 infection. In Iran, we have documented our experiences with the virus in order to achieve and promote the possible ways to manage, control, and eliminate HTLV-1. Although there has been considerable progress apropos of HTLV-1, a series of additional challenges need to be tackled to control HTLV-1 infection in Iran.
Keywords :
ATL , HAM , TSP , HTLV , 1 , Prevention , Treatments
Journal title :
Iranian Journal of Basic Medical Sciences
Journal title :
Iranian Journal of Basic Medical Sciences
